{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:38:47Z","timestamp":1793911127342,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-111227"],"award-info":[{"award-number":["TSGH-E-111227"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Defense Medical University","award":["MND-MAB-E-113081"],"award-info":[{"award-number":["MND-MAB-E-113081"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48699-6","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:51:35Z","timestamp":1776347495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual antiviral and anti-inflammatory effects of BAY 11-7082 in SARS-CoV-2 infection via inhibition of the canonical NF-\u03baB signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Po-Chih","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Sian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsi","family":"Tso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Chuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Ai","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Tun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wen","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Mao","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"48699_CR1","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","volume":"28","author":"B Bowe","year":"2022","unstructured":"Bowe, B., Xie, Y. & Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 28, 2398\u20132405. https:\/\/doi.org\/10.1038\/s41591-022-02051-3 (2022).","journal-title":"Nat. Med."},{"key":"48699_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.28.25324858","author":"B Zhang","year":"2025","unstructured":"Zhang, B. et al. Reinfection with SARS-CoV-2 in the Omicron Era is associated with increased risk of post-acute sequelae of SARS-CoV-2 infection: A RECOVER-EHR cohort study. medRxiv https:\/\/doi.org\/10.1101\/2025.03.28.25324858 (2025).","journal-title":"medRxiv"},{"key":"48699_CR3","doi-asserted-by":"publisher","first-page":"118923","DOI":"10.1016\/j.lfs.2020.118923","volume":"267","author":"R Hirawat","year":"2021","unstructured":"Hirawat, R., Saifi, M. A. & Godugu, C. Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications. Life Sci. 267, 118923. https:\/\/doi.org\/10.1016\/j.lfs.2020.118923 (2021).","journal-title":"Life Sci."},{"key":"48699_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.anai.2024.08.021","volume":"133","author":"MR Elliott","year":"2024","unstructured":"Elliott, M. R., O\u2019Connor, A. E. & Marshall, G. D. Inflammatory pathways in patients with post-acute sequelae of COVID-19: The role of the clinical immunologist. Ann. Allergy Asthma Immunol. 133, 507\u2013515. https:\/\/doi.org\/10.1016\/j.anai.2024.08.021 (2024).","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"48699_CR5","doi-asserted-by":"publisher","first-page":"1085988","DOI":"10.3389\/fmed.2023.1085988","volume":"10","author":"YJ Lai","year":"2023","unstructured":"Lai, Y. J. et al. Biomarkers in long COVID-19: A systematic review. Front. Med. 10, 1085988. https:\/\/doi.org\/10.3389\/fmed.2023.1085988 (2023).","journal-title":"Front. Med."},{"issue":"4","key":"48699_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1515\/mr-2024-0013","volume":"2021","author":"M Guo","year":"2024","unstructured":"Guo, M. et al. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis\/mechanisms of long COVID. Med. Rev. 2021 (4), 367\u2013383. https:\/\/doi.org\/10.1515\/mr-2024-0013 (2024).","journal-title":"Med. Rev."},{"key":"48699_CR7","doi-asserted-by":"publisher","first-page":"e29333","DOI":"10.1002\/jmv.29333","volume":"96","author":"MS Durstenfeld","year":"2024","unstructured":"Durstenfeld, M. S. et al. Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study. J. Med. Virol. 96, e29333. https:\/\/doi.org\/10.1002\/jmv.29333 (2024).","journal-title":"J. Med. Virol."},{"key":"48699_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12879-023-08952-z","volume":"24","author":"HT Pham","year":"2024","unstructured":"Pham, H. T., Mai-Phan, T. A., Truong-Nguyen, K. H. & Tran, M. H. Effects of antivirals on patients with COVID-19 breakthrough. BMC Infect. Dis. 24, 25. https:\/\/doi.org\/10.1186\/s12879-023-08952-z (2024).","journal-title":"BMC Infect. Dis."},{"key":"48699_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.cmi.2024.07.006","volume":"30","author":"G Sun","year":"2024","unstructured":"Sun, G., Lin, K., Ai, J. & Zhang, W. The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: A systematic review and meta-analysis. Clin. Microbiol. Infect. 30, 1505\u20131513. https:\/\/doi.org\/10.1016\/j.cmi.2024.07.006 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"48699_CR10","doi-asserted-by":"publisher","first-page":"10736","DOI":"10.1073\/pnas.112338099","volume":"99","author":"GK Geiss","year":"2002","unstructured":"Geiss, G. K. et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. USA 99, 10736\u201310741. https:\/\/doi.org\/10.1073\/pnas.112338099 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48699_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1086\/344644","volume":"186","author":"HA Haeberle","year":"2002","unstructured":"Haeberle, H. A. et al. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J. Infect. Dis. 186, 1199\u20131206. https:\/\/doi.org\/10.1086\/344644 (2002).","journal-title":"J. Infect. Dis."},{"key":"48699_CR12","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/mi.2017.120","volume":"11","author":"A Kalinowski","year":"2018","unstructured":"Kalinowski, A. et al. Respiratory syncytial virus activates Epidermal growth factor receptor to suppress Interferon regulatory factor 1-dependent Interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunol. 11, 958\u2013967. https:\/\/doi.org\/10.1038\/mi.2017.120 (2018).","journal-title":"Mucosal Immunol."},{"key":"48699_CR13","doi-asserted-by":"publisher","first-page":"108449","DOI":"10.1016\/j.isci.2023.108449","volume":"26","author":"A Bhargava","year":"2023","unstructured":"Bhargava, A. et al. Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-\u03baB pathway toward SARS-CoV-2. iScience 26, 108449. https:\/\/doi.org\/10.1016\/j.isci.2023.108449 (2023).","journal-title":"iScience"},{"key":"48699_CR14","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724. https:\/\/doi.org\/10.1126\/science.abc6027 (2020).","journal-title":"Science"},{"key":"48699_CR15","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036-1045 e1039. https:\/\/doi.org\/10.1016\/j.cell.2020.04.026 (2020).","journal-title":"Cell"},{"key":"48699_CR16","doi-asserted-by":"publisher","first-page":"e0125721","DOI":"10.1128\/JVI.01257-21","volume":"95","author":"BE Nilsson-Payant","year":"2021","unstructured":"Nilsson-Payant, B. E. et al. The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication. J. Virol. 95, e0125721. https:\/\/doi.org\/10.1128\/JVI.01257-21 (2021).","journal-title":"J. Virol."},{"key":"48699_CR17","doi-asserted-by":"publisher","first-page":"1007089","DOI":"10.3389\/fimmu.2022.1007089","volume":"13","author":"TW Li","year":"2022","unstructured":"Li, T. W. et al. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-kappaB signaling. Front. Immunol. 13, 1007089. https:\/\/doi.org\/10.3389\/fimmu.2022.1007089 (2022).","journal-title":"Front. Immunol."},{"key":"48699_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RC Group","year":"2021","unstructured":"Group, R. C. et al. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436 (2021).","journal-title":"N. Engl. J. Med."},{"key":"48699_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10096-020-04085-2","volume":"40","author":"Z Hu","year":"2021","unstructured":"Hu, Z. et al. Delayed hospital admission and high-dose corticosteroids potentially prolong SARS-CoV-2 RNA detection duration of patients with COVID-19. Eur. J. Clin. Microbiol. Infect. Dis. 40, 841\u2013848. https:\/\/doi.org\/10.1007\/s10096-020-04085-2 (2021).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"48699_CR20","doi-asserted-by":"publisher","first-page":"173556","DOI":"10.1016\/j.ejphar.2020.173556","volume":"889","author":"R Huang","year":"2020","unstructured":"Huang, R. et al. Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients. Eur. J. Pharmacol. 889, 173556. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173556 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"48699_CR21","doi-asserted-by":"publisher","first-page":"105066","DOI":"10.1016\/j.isci.2022.105066","volume":"25","author":"E Laplantine","year":"2022","unstructured":"Laplantine, E. et al. The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-\u03baB signaling. iScience 25, 105066. https:\/\/doi.org\/10.1016\/j.isci.2022.105066 (2022).","journal-title":"iScience"},{"key":"48699_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cellsig.2009.02.025","volume":"21","author":"S Mendes Sdos","year":"2009","unstructured":"Mendes Sdos, S. et al. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression. Cell Signal 21, 1109\u20131122. https:\/\/doi.org\/10.1016\/j.cellsig.2009.02.025 (2009).","journal-title":"Cell Signal"},{"key":"48699_CR23","doi-asserted-by":"publisher","first-page":"416036","DOI":"10.1155\/2012\/416036","volume":"2012","author":"J Lee","year":"2012","unstructured":"Lee, J., Rhee, M. H., Kim, E. & Cho, J. Y. BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets. Mediat. Inflamm. 2012, 416036. https:\/\/doi.org\/10.1155\/2012\/416036 (2012).","journal-title":"Mediat. Inflamm."},{"key":"48699_CR24","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","volume":"285","author":"C Juliana","year":"2010","unstructured":"Juliana, C. et al. Anti-inflammatory compounds parthenolide and Bay 11\u20137082 are direct inhibitors of the inflammasome. J. Biol. Chem. 285, 9792\u20139802. https:\/\/doi.org\/10.1074\/jbc.M109.082305 (2010).","journal-title":"J. Biol. Chem."},{"key":"48699_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.antiviral.2011.05.009","volume":"92","author":"R Pinto","year":"2011","unstructured":"Pinto, R. et al. Inhibition of influenza virus-induced NF-kappaB and Raf\/MEK\/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo. Antivir. Res. 92, 45\u201356. https:\/\/doi.org\/10.1016\/j.antiviral.2011.05.009 (2011).","journal-title":"Antivir. Res."},{"key":"48699_CR26","doi-asserted-by":"publisher","first-page":"9880","DOI":"10.1128\/JVI.00909-08","volume":"82","author":"N Kumar","year":"2008","unstructured":"Kumar, N., Xin, Z. T., Liang, Y., Ly, H. & Liang, Y. NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 82, 9880\u20139889. https:\/\/doi.org\/10.1128\/JVI.00909-08 (2008).","journal-title":"J. Virol."},{"key":"48699_CR27","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.isci.2020.101947","volume":"24","author":"SA Thair","year":"2021","unstructured":"Thair, S. A. et al. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections. iScience 24, 101947. https:\/\/doi.org\/10.1016\/j.isci.2020.101947 (2021).","journal-title":"iScience"},{"key":"48699_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/v14071369","author":"CW Chang","year":"2022","unstructured":"Chang, C. W. et al. A newly engineered A549 cell line expressing ACE2 and TMPRSS2 is highly permissive to SARS-CoV-2, including the Delta and Omicron variants. Viruses https:\/\/doi.org\/10.3390\/v14071369 (2022).","journal-title":"Viruses"},{"key":"48699_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/v13091735","author":"D Grebennikov","year":"2021","unstructured":"Grebennikov, D. et al. Intracellular life cycle kinetics of SARS-CoV-2 predicted using mathematical modelling. Viruses https:\/\/doi.org\/10.3390\/v13091735 (2021).","journal-title":"Viruses"},{"key":"48699_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jaci.2021.05.032","volume":"148","author":"Y Zaid","year":"2021","unstructured":"Zaid, Y. et al. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. J. Allergy Clin. Immunol. 148, 368\u2013380. https:\/\/doi.org\/10.1016\/j.jaci.2021.05.032 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"48699_CR31","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2355-0","volume":"583","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Viral and host factors related to the clinical outcome of COVID-19. Nature 583, 437\u2013440. https:\/\/doi.org\/10.1038\/s41586-020-2355-0 (2020).","journal-title":"Nature"},{"key":"48699_CR32","doi-asserted-by":"publisher","first-page":"907422","DOI":"10.3389\/fmicb.2022.907422","volume":"13","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Genome-wide analysis of the indispensable role of non-structural proteins in the replication of SARS-CoV-2. Front. Microbiol. 13, 907422. https:\/\/doi.org\/10.3389\/fmicb.2022.907422 (2022).","journal-title":"Front. Microbiol."},{"key":"48699_CR33","doi-asserted-by":"publisher","first-page":"e71945","DOI":"10.7554\/eLife.71945","volume":"11","author":"M Zaffagni","year":"2022","unstructured":"Zaffagni, M. et al. SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome. Elife 11, e71945. https:\/\/doi.org\/10.7554\/eLife.71945 (2022).","journal-title":"Elife"},{"key":"48699_CR34","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41556-024-01388-w","volume":"26","author":"T Duan","year":"2024","unstructured":"Duan, T. et al. ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection. Nat. Cell Biol. 26, 628\u2013644. https:\/\/doi.org\/10.1038\/s41556-024-01388-w (2024).","journal-title":"Nat. Cell Biol."},{"key":"48699_CR35","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20231418","author":"MJ Tofaute","year":"2024","unstructured":"Tofaute, M. J. et al. SARS-CoV-2 NSP14 MTase activity is critical for inducing canonical NF-kappaB activation. Biosci. Rep. https:\/\/doi.org\/10.1042\/BSR20231418 (2024)."},{"key":"48699_CR36","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08320-0","volume":"637","author":"C Meyer","year":"2025","unstructured":"Meyer, C. et al. Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase. Nature 637, 1178\u20131185. https:\/\/doi.org\/10.1038\/s41586-024-08320-0 (2025).","journal-title":"Nature"},{"key":"48699_CR37","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/nar\/gkac1207","volume":"51","author":"N Imprachim","year":"2023","unstructured":"Imprachim, N., Yosaatmadja, Y. & Newman, J. A. Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development. Nucleic Acids Res. 51, 475\u2013487. https:\/\/doi.org\/10.1093\/nar\/gkac1207 (2023).","journal-title":"Nucleic Acids Res."},{"key":"48699_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12964-024-01949-4","volume":"22","author":"F Hua","year":"2024","unstructured":"Hua, F. et al. Linear ubiquitination mediates coronavirus NSP14-induced NF-kappaB activation. Cell Commun. Signal 22, 573. https:\/\/doi.org\/10.1186\/s12964-024-01949-4 (2024).","journal-title":"Cell Commun. Signal"},{"key":"48699_CR39","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41594-022-00828-1","volume":"29","author":"J Kottur","year":"2022","unstructured":"Kottur, J., Rechkoblit, O., Quintana-Feliciano, R., Sciaky, D. & Aggarwal, A. K. High-resolution structures of the SARS-CoV-2 N7-methyltransferase inform therapeutic development. Nat. Struct. Mol. Biol. 29, 850\u2013853. https:\/\/doi.org\/10.1038\/s41594-022-00828-1 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"48699_CR40","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/med.21941","volume":"43","author":"X He","year":"2023","unstructured":"He, X., He, C., Hong, W., Yang, J. & Wei, X. Research progress in spike mutations of SARS-CoV-2 variants and vaccine development. Med. Res. Rev. 43, 932\u2013971. https:\/\/doi.org\/10.1002\/med.21941 (2023).","journal-title":"Med. Res. Rev."},{"key":"48699_CR41","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.chom.2021.06.018","volume":"29","author":"M Merad","year":"2021","unstructured":"Merad, M., Subramanian, A. & Wang, T. T. An aberrant inflammatory response in severe COVID-19. Cell Host Microbe 29, 1043\u20131047. https:\/\/doi.org\/10.1016\/j.chom.2021.06.018 (2021).","journal-title":"Cell Host Microbe"},{"key":"48699_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.20411\/pai.v7i2.537","volume":"7","author":"L Grimm","year":"2022","unstructured":"Grimm, L. et al. Immune dysregulation in acute SARS-CoV-2 infection. Pathog. Immun. 7, 143\u2013170. https:\/\/doi.org\/10.20411\/pai.v7i2.537 (2022).","journal-title":"Pathog. Immun."},{"key":"48699_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12291-022-01108-x","volume":"38","author":"V Tiwari","year":"2023","unstructured":"Tiwari, V., Agarwal, J., Pathak, A. K. & Singh, S. Dynamic changes in circulatory cytokines and chemokines levels in mild to severe COVID-19 patients. Indian J. Clin. Biochem. 38, 212\u2013219. https:\/\/doi.org\/10.1007\/s12291-022-01108-x (2023).","journal-title":"Indian J. Clin. Biochem."},{"key":"48699_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.24272\/j.issn.2095-8137.2021.469","volume":"43","author":"ML Wu","year":"2022","unstructured":"Wu, M. L. et al. Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice. Zool. Res. 43, 457\u2013468. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2021.469 (2022).","journal-title":"Zool. Res."},{"key":"48699_CR45","doi-asserted-by":"publisher","first-page":"17146","DOI":"10.1038\/s41598-021-96462-w","volume":"11","author":"G Sun","year":"2021","unstructured":"Sun, G. et al. Comparative transcriptomic analysis of SARS-CoV-2 infected cell model systems reveals differential innate immune responses. Sci. Rep. 11, 17146. https:\/\/doi.org\/10.1038\/s41598-021-96462-w (2021).","journal-title":"Sci. Rep."},{"key":"48699_CR46","doi-asserted-by":"publisher","first-page":"107863","DOI":"10.1016\/j.celrep.2020.107863","volume":"32","author":"ML Stanifer","year":"2020","unstructured":"Stanifer, M. L. et al. Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells. Cell Rep. 32, 107863. https:\/\/doi.org\/10.1016\/j.celrep.2020.107863 (2020).","journal-title":"Cell Rep."},{"key":"48699_CR47","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1128\/JVI.73.5.3893-3903.1999","volume":"73","author":"S Asin","year":"1999","unstructured":"Asin, S., Taylor, J. A., Trushin, S., Bren, G. & Paya, C. V. Ikappakappa mediates NF-kappaB activation in human immunodeficiency virus-infected cells. J. Virol. 73, 3893\u20133903. https:\/\/doi.org\/10.1128\/JVI.73.5.3893-3903.1999 (1999).","journal-title":"J. Virol."},{"key":"48699_CR48","doi-asserted-by":"publisher","first-page":"15595","DOI":"10.1073\/pnas.2136756100","volume":"100","author":"M Luftig","year":"2003","unstructured":"Luftig, M. et al. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. Proc. Natl. Acad. Sci. USA 100, 15595\u201315600. https:\/\/doi.org\/10.1073\/pnas.2136756100 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48699_CR49","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/cmi.12005","volume":"14","author":"S Gao","year":"2012","unstructured":"Gao, S. et al. Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell. Microbiol. 14, 1849\u20131866. https:\/\/doi.org\/10.1111\/cmi.12005 (2012).","journal-title":"Cell. Microbiol."},{"key":"48699_CR50","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.26.445787","author":"T Li","year":"2021","unstructured":"Li, T. et al. SARS-CoV-2 Nsp14 activates NF-kappaB signaling and induces IL-8 upregulation. bioRxiv https:\/\/doi.org\/10.1101\/2021.05.26.445787 (2021).","journal-title":"bioRxiv"},{"key":"48699_CR51","doi-asserted-by":"publisher","first-page":"199086","DOI":"10.1016\/j.virusres.2023.199086","volume":"328","author":"Y Nie","year":"2023","unstructured":"Nie, Y. et al. SARS-CoV-2 ORF3a positively regulates NF-kappaB activity by enhancing IKKbeta-NEMO interaction. Virus Res 328, 199086. https:\/\/doi.org\/10.1016\/j.virusres.2023.199086 (2023).","journal-title":"Virus Res"},{"key":"48699_CR52","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41440-023-01460-2","volume":"47","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. The role of SARS-CoV-2-mediated NF-kappaB activation in COVID-19 patients. Hypertens Res. 47, 375\u2013384. https:\/\/doi.org\/10.1038\/s41440-023-01460-2 (2024).","journal-title":"Hypertens Res."},{"key":"48699_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","volume":"23","author":"B Malone","year":"2022","unstructured":"Malone, B., Urakova, N., Snijder, E. J. & Campbell, E. A. Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design. Nat. Rev. Mol. Cell Biol. 23, 21\u201339. https:\/\/doi.org\/10.1038\/s41580-021-00432-z (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"48699_CR54","doi-asserted-by":"publisher","first-page":"940756","DOI":"10.3389\/fimmu.2022.940756","volume":"13","author":"F Rashid","year":"2022","unstructured":"Rashid, F. et al. Roles and functions of SARS-CoV-2 proteins in host immune evasion. Front. Immunol. 13, 940756. https:\/\/doi.org\/10.3389\/fimmu.2022.940756 (2022).","journal-title":"Front. Immunol."},{"key":"48699_CR55","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei, X. et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 11, 3810. https:\/\/doi.org\/10.1038\/s41467-020-17665-9 (2020).","journal-title":"Nat. Commun."},{"key":"48699_CR56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101161118","author":"JC Hsu","year":"2021","unstructured":"Hsu, J. C., Laurent-Rolle, M., Pawlak, J. B., Wilen, C. B. & Cresswell, P. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.2101161118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48699_CR57","doi-asserted-by":"publisher","first-page":"9671","DOI":"10.1038\/s41467-025-64674-7","volume":"16","author":"M Luo","year":"2025","unstructured":"Luo, M. et al. SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulation. Nat. Commun. 16, 9671. https:\/\/doi.org\/10.1038\/s41467-025-64674-7 (2025).","journal-title":"Nat. Commun."},{"key":"48699_CR58","doi-asserted-by":"publisher","first-page":"e0219422","DOI":"10.1128\/spectrum.02194-22","volume":"11","author":"LG Gardinassi","year":"2023","unstructured":"Gardinassi, L. G. et al. Integrated metabolic and inflammatory signatures associated with severity of, fatality of, and recovery from COVID-19. Microbiol. Spectr. 11, e0219422. https:\/\/doi.org\/10.1128\/spectrum.02194-22 (2023).","journal-title":"Microbiol. Spectr."},{"key":"48699_CR59","doi-asserted-by":"publisher","first-page":"105114","DOI":"10.1016\/j.micpath.2021.105114","volume":"158","author":"STR Moolamalla","year":"2021","unstructured":"Moolamalla, S. T. R., Balasubramanian, R., Chauhan, R., Priyakumar, U. D. & Vinod, P. K. Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach. Microb. Pathog. 158, 105114. https:\/\/doi.org\/10.1016\/j.micpath.2021.105114 (2021).","journal-title":"Microb. Pathog."},{"key":"48699_CR60","doi-asserted-by":"publisher","first-page":"e28263","DOI":"10.4161\/trns.28263","volume":"5","author":"H Zeng","year":"2014","unstructured":"Zeng, H. & Chi, H. mTOR signaling and transcriptional regulation in T lymphocytes. Transcription 5, e28263. https:\/\/doi.org\/10.4161\/trns.28263 (2014).","journal-title":"Transcription"},{"key":"48699_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12879-024-08983-0","volume":"24","author":"W Munawar","year":"2024","unstructured":"Munawar, W. et al. Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: A systematic review and integrated bioinformatics analysis. BMC Infect. Dis. 24, 124. https:\/\/doi.org\/10.1186\/s12879-024-08983-0 (2024).","journal-title":"BMC Infect. Dis."},{"key":"48699_CR62","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s42255-021-00479-4","volume":"3","author":"J Chu","year":"2021","unstructured":"Chu, J. et al. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication. Nat. Metab. 3, 1466\u20131475. https:\/\/doi.org\/10.1038\/s42255-021-00479-4 (2021).","journal-title":"Nat. Metab."},{"key":"48699_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmet.2021.12.002","volume":"34","author":"M Zickler","year":"2022","unstructured":"Zickler, M. et al. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. 34, 1\u20132. https:\/\/doi.org\/10.1016\/j.cmet.2021.12.002 (2022).","journal-title":"Cell Metab."},{"key":"48699_CR64","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"48699_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biologicals.2022.08.002","volume":"79","author":"PL Lin","year":"2022","unstructured":"Lin, P. L. et al. A collaborative study to establish the national standard for SARS-CoV-2 RNA nucleic acid amplification techniques (NAAT) in Taiwan. Biologicals 79, 31\u201337. https:\/\/doi.org\/10.1016\/j.biologicals.2022.08.002 (2022).","journal-title":"Biologicals"},{"key":"48699_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"48699_CR67","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419. https:\/\/doi.org\/10.1038\/nmeth.4197 (2017).","journal-title":"Nat. Methods"},{"key":"48699_CR68","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"48699_CR69","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell Syst."},{"key":"48699_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12250-020-00230-5","volume":"36","author":"C Lei","year":"2021","unstructured":"Lei, C., Yang, J., Hu, J. & Sun, X. On the calculation of TCID(50) for quantitation of virus infectivity. Virol. Sin. 36, 141\u2013144. https:\/\/doi.org\/10.1007\/s12250-020-00230-5 (2021).","journal-title":"Virol. Sin."},{"key":"48699_CR71","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina, D. et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341, 84\u201387. https:\/\/doi.org\/10.1126\/science.1233606 (2013).","journal-title":"Science"},{"key":"48699_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/v13040562","author":"EK Loveday","year":"2021","unstructured":"Loveday, E. K. et al. Effect of inactivation methods on SARS-CoV-2 virion protein and structure. Viruses https:\/\/doi.org\/10.3390\/v13040562 (2021).","journal-title":"Viruses"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48699-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48699-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48699-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:31:26Z","timestamp":1780957886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48699-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48699"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48699-6","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20231418","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17714"}}